Merck to acquire biopharmaceutical company Idenix for $3.85 billion

12:42 PM | June 9, 2014 | Natasha Alperowicz

Merck said today that it has entered into a definitive agreement to acquire of biopharmaceuticals company Idenix Pharmaceuticals (Cambridge, MA) for $24.50/share in cash. The boards of directors of...